WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - General
Best General Drug Manufacturer Stocks to Buy Now (2024)
Top general drug manufacturer stocks in 2024 ranked by overall Zen Score. See the best general drug manufacturer stocks to buy now, according to analyst forecasts for the drug manufacturers - general industry.

Industry: Drug Manufacturers - Gene...
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
JNJ
JOHNSON & JOHNSON
NYSE
Drug Manufacturers - General
$350.53B$145.65-0.21%$49.47B9.54x1.46
LLY
ELI LILLY & CO
NYSE
Drug Manufacturers - General
$847.25B$891.460.73%$9.13B130.71x3.98
AZN
ASTRAZENECA PLC
NASDAQ
Drug Manufacturers - General
$243.13B$78.42-1.12%$14.25B38.35x1.73
NVS
NOVARTIS AG
NYSE
Drug Manufacturers - General
$214.12B$104.940.01%N/A14.16x1.38
SNY
SANOFI
NASDAQ
Drug Manufacturers - General
$119.45B$47.22-0.15%$14.09B20.38x0.70
GSK
GSK PLC
NYSE
Drug Manufacturers - General
$82.80B$40.950.71%$7.29B15.01x3.27
BIIB
BIOGEN INC
NASDAQ
Drug Manufacturers - General
$32.56B$223.65-1.24%$1.85B27.78x0.75
ABBV
ABBVIE INC
NYSE
Drug Manufacturers - General
$302.60B$171.360.99%$17.85B50.85x17.59
GILD
GILEAD SCIENCES INC
NASDAQ
Drug Manufacturers - General
$78.68B$63.15-1.74%$4.81B157.88x2.21
AMGN
AMGEN INC
NASDAQ
Drug Manufacturers - General
$164.14B$305.990.89%$12.07B43.46x17.52
MRK
MERCK & CO INC
NYSE
Drug Manufacturers - General
$324.17B$127.990.38%$8.97B140.65x1.62
BMY
BRISTOL MYERS SQUIBB CO
NYSE
Drug Manufacturers - General
$82.73B$40.81-0.39%$4.00B-13.21x5.00
GRFS
GRIFOLS SA
NASDAQ
Drug Manufacturers - General
$4.83B$7.02-1.13%$1.23B72.37x2.31
PFE
PFIZER INC
NYSE
Drug Manufacturers - General
$155.32B$27.411.59%$4.69B-548.20x1.39
OGN
ORGANON & CO
NYSE
Drug Manufacturers - General
$5.23B$20.350.00%$1.44B4.96x246.73
SCLX
SCILEX HOLDING CO
NASDAQ
Drug Manufacturers - General
$331.58M$1.83-14.88%-$101.67M-1.40x-1.48
AMRN
AMARIN CORP PLC
NASDAQ
Drug Manufacturers - General
$299.93M$0.73-3.69%-$46.02M-5.62x0.45
MIRA
MIRA PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - General
$10.49M$0.71-1.39%-$8.95M-1.06x0.21

General Drug Manufacturer Stocks FAQ

What are the best general drug manufacturer stocks to buy right now in Jun 2024?

According to Zen Score, the 3 best general drug manufacturer stocks to buy right now are:

1. Johnson & Johnson (NYSE:JNJ)


Johnson & Johnson (NYSE:JNJ) is the top general drug manufacturer stock with a Zen Score of 58, which is 21 points higher than the general drug manufacturer industry average of 37. It passed 21 out of 38 due diligence checks and has strong fundamentals. Johnson & Johnson has seen its stock lose -11.26% over the past year, underperforming other general drug manufacturer stocks by -34 percentage points.

Johnson & Johnson has an average 1 year price target of $178.67, an upside of 22.67% from Johnson & Johnson's current stock price of $145.65.

Johnson & Johnson stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Johnson & Johnson, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Eli Lilly & Co (NYSE:LLY)


Eli Lilly & Co (NYSE:LLY) is the second best general drug manufacturer stock with a Zen Score of 55, which is 18 points higher than the general drug manufacturer industry average of 37. It passed 22 out of 38 due diligence checks and has strong fundamentals. Eli Lilly & Co has seen its stock return 97.25% over the past year, overperforming other general drug manufacturer stocks by 74 percentage points.

Eli Lilly & Co has an average 1 year price target of $852.06, a downside of -4.42% from Eli Lilly & Co's current stock price of $891.46.

Eli Lilly & Co stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Eli Lilly & Co, 75% have issued a Strong Buy rating, 12.5% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Novartis Ag (NYSE:NVS)


Novartis Ag (NYSE:NVS) is the third best general drug manufacturer stock with a Zen Score of 51, which is 14 points higher than the general drug manufacturer industry average of 37. It passed 19 out of 38 due diligence checks and has strong fundamentals. Novartis Ag has seen its stock return 4.09% over the past year, underperforming other general drug manufacturer stocks by -19 percentage points.

Novartis Ag has an average 1 year price target of $115.00, an upside of 9.59% from Novartis Ag's current stock price of $104.94.

Novartis Ag stock has a consensus Hold recommendation according to Wall Street analysts. Of the 2 analysts covering Novartis Ag, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the general drug manufacturer stocks with highest dividends?

Out of 12 general drug manufacturer stocks that have issued dividends in the past year, the 3 general drug manufacturer stocks with the highest dividend yields are:

1. Pfizer (NYSE:PFE)


Pfizer (NYSE:PFE) has an annual dividend yield of 6.06%, which is 3 percentage points higher than the general drug manufacturer industry average of 3.38%. Pfizer's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Pfizer's dividend has shown consistent growth over the last 10 years.

Pfizer's dividend payout ratio of -3,300% indicates that its high dividend yield might not be sustainable for the long-term.

2. Bristol Myers Squibb Co (NYSE:BMY)


Bristol Myers Squibb Co (NYSE:BMY) has an annual dividend yield of 5.73%, which is 2 percentage points higher than the general drug manufacturer industry average of 3.38%. Bristol Myers Squibb Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Bristol Myers Squibb Co's dividend has shown consistent growth over the last 10 years.

Bristol Myers Squibb Co's dividend payout ratio of -75.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Gilead Sciences (NASDAQ:GILD)


Gilead Sciences (NASDAQ:GILD) has an annual dividend yield of 4.81%, which is 1 percentage points higher than the general drug manufacturer industry average of 3.38%. Gilead Sciences's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Gilead Sciences's dividend has shown consistent growth over the last 10 years.

Gilead Sciences's dividend payout ratio of 755% indicates that its high dividend yield might not be sustainable for the long-term.

Why are general drug manufacturer stocks up?

General drug manufacturer stocks were up 0.27% in the last day, and up 0.95% over the last week. Merck & Co was the among the top gainers in the drug manufacturers - general industry, gaining 0.38% yesterday.

Merck shares are trading higher after the FDA approved CAPVAXIVE for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.

What are the most undervalued general drug manufacturer stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued general drug manufacturer stocks right now are:

1. Biogen (NASDAQ:BIIB)


Biogen (NASDAQ:BIIB) is the most undervalued general drug manufacturer stock based on WallStreetZen's Valuation Score. Biogen has a valuation score of 86, which is 55 points higher than the general drug manufacturer industry average of 31. It passed 6 out of 7 valuation due diligence checks.

Biogen's stock has dropped -23.87% in the past year. It has underperformed other stocks in the general drug manufacturer industry by -47 percentage points.

2. Sanofi (NASDAQ:SNY)


Sanofi (NASDAQ:SNY) is the second most undervalued general drug manufacturer stock based on WallStreetZen's Valuation Score. Sanofi has a valuation score of 57, which is 26 points higher than the general drug manufacturer industry average of 31. It passed 4 out of 7 valuation due diligence checks.

Sanofi's stock has dropped -11.07% in the past year. It has underperformed other stocks in the general drug manufacturer industry by -34 percentage points.

3. Gsk (NYSE:GSK)


Gsk (NYSE:GSK) is the third most undervalued general drug manufacturer stock based on WallStreetZen's Valuation Score. Gsk has a valuation score of 57, which is 26 points higher than the general drug manufacturer industry average of 31. It passed 4 out of 7 valuation due diligence checks.

Gsk's stock has gained 18.28% in the past year. It has underperformed other stocks in the general drug manufacturer industry by -5 percentage points.

Are general drug manufacturer stocks a good buy now?

53.33% of general drug manufacturer stocks rated by analysts are a buy right now. On average, analysts expect general drug manufacturer stocks to rise by 7.57% over the next year.

What is the average p/e ratio of the drug manufacturers - general industry?

The average P/E ratio of the drug manufacturers - general industry is 41.79x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.